Physician profile
Charles E Hoffler
NPI 1043496896
$4,600.54
in general payments reported to CMS, 2019-2025
16 companies · $570 in 2025
The $570 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $2,071 · 2021: $136 · 2022: $814 · 2023: $234 · 2024: $84.15 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $500 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $500.00 |
| Food and Beverage | $387.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $2,000.00 | 2020-2025 | Ijs, Align, Geminus |
| Arthrex, INC. | $996.75 | 2020 | |
| Lima USA, INC. | $553.54 | 2019 | |
| Stryker Corporation | $395.37 | 2020-2023 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Aequalis Perform Reversed |
| Axogen | $188.06 | 2019-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Fx Shoulder Solutions, INC | $81.68 | 2023 | |
| Zimmer Biomet Holdings, INC. | $68.90 | 2019-2022 | |
| Depuy Synthes Sales INC. | $52.76 | 2022 | |
| Smith+Nephew, INC. | $51.67 | 2019 | |
| Ermi LLC | $51.03 | 2025 | |
| Integra Lifesciences Corporation | $40.32 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Amgen INC. | $30.97 | 2024 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $25.00 | 2024 | Nuzyra |
| Osteocentric Technologies, INC. | $24.87 | 2019 | |
| Djo, LLC | $20.86 | 2023 | Cmf |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.76 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hoffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.